Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Pediatr Res. 2022 Jul 29;93(2):316–323. doi: 10.1038/s41390-022-02206-5

Figure 2. Candidate miRNAs for the diagnosis and therapy of pediatric diseases.

Figure 2.

Top miRNA candidates for diagnosis/prognosis (A), and therapy (B) of pediatric diseases are displayed. Diseases of interest were selected based on their abundance of miRNA literature, and to reflect the ability of miRNAs to detect or treat pathology in organ systems throughout the body. In disease states where numerous miRNA candidates have been identified, ≤ 4 miRNAs are displayed based upon their detection across multiple studies, or their detection in studies with large sample sizes. The number after each miRNA denotes the reference paper in which it was reported. Abbreviations: Type 1 diabetes mellitus (T1DM); Bronchopulmonary dysplasia (BPD); Acute lymphoblastic leukemia (ALL); Duchene’s muscular dystrophy (DMD).